Evidence map›Paper›PMID 21852800›Full record

ReviewNature reviews. Neuroscience2011

Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine.

Andreas Meyer-Lindenberg, Gregor Domes, Peter Kirsch, Markus Heinrichs

2 registry-linked trialsAbstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Neuroscience, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 727 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
727citing papers in PubMed, 8 pooled it
145.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02526914 naunknown statusnot on this mapstarted 2015, after this paper: background citation

Effects of Intranasal Oxytocin and Vasopressin on Social Behavior and Decision Making

TypeinterventionalSponsorDavid MankutaRan2015 to 2017Enrolled432ConditionsHealthyArmsIntranasal Oxytocin, Intranasal vasopressin, Intranasal placebo
NCT05766852 nacompletednot on this mapstarted 2023, after this paper: background citation

Potential Benefits of the Somatic Psychoeducational Intervention for Improving the Health and Wellness of Healthcare Providers

TypeinterventionalSponsorUniversity of FloridaRan2023 to 2024Enrolled31ConditionsWork Related StressArmsSomatic Psychoeducational Intervention
3 · Its place in the literature

Who cites it

727 citing papers in PubMed, 8 syntheses or guidelines pooled it, 1,686 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Oxytocin effects on amygdala reactivity to angry faces in males and females with antisocial personality disorder.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2023
    Trial
  20. Trial

667 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Andreas Meyer-LindenbergCentral Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Square J5, D-68159 Mannheim, Germany. a.meyer-lindenberg@zi-mannheim.de
Gregor Domes
Peter Kirsch
Markus Heinrichs
University of Freiburg · DECentral Institute of Mental Health · DEHeidelberg University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The neuropeptides oxytocin (OXT) and arginine vasopressin (AVP) are evolutionarily highly conserved mediators in the regulation of complex social cognition and behaviour. Recent studies have investigated the effects of OXT and AVP on human social interaction, the genetic mechanisms of inter-individual variation in social neuropeptide signalling and the actions of OXT and AVP in the human brain as revealed by neuroimaging. These data have advanced our understanding of the mechanisms by which these neuropeptides contribute to human social behaviour. OXT and AVP are emerging as targets for novel treatment approaches--particularly in synergistic combination with psychotherapy--for mental disorders characterized by social dysfunction, such as autism, social anxiety disorder, borderline personality disorder and schizophrenia.

Indexed as

Interpersonal RelationsAnimalsHumansNeural PathwaysNeuropeptidesOxytocinSocial BehaviorTranslational Research, BiomedicalVasopressinsNeuropeptidesOxytocinVasopressins

Identifiers

PMID21852800
OpenAlexW2023636464

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.